Most Common Side Effects Nausea (3560% across doses) Common in early weeks and after increases
GPF received honoraria for speaker activities, for serving on advisory boards, or consultancy from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Guidotti, Novartis, Novo Nordisk, and Sanofi
So far, there's nothing different about how this is working from any retail supply chain, but here's where it gets weird
For people taking between 0.5 mg and 2.4 mg of subcutaneous semaglutide, nausea increased from 23% of those taking 0.5 mg to 68% of those taking 2.4 mg, and vomiting increased from 9% to 45%
If 5 mg per week is producing the weight loss outcomes you want, staying there is perfectly reasonable